4/A: Castle Biosciences Director Rodney Cotton Acquires 6,777 Restricted Stock Units

Director Rodney Cotton acquired 6,777 Restricted Stock Units in Castle Biosciences, vesting in equal annual installments starting May 23, 2025.

Summary

• Rodney Cotton, a director of Castle Biosciences, acquired 6,777 Restricted Stock Units (RSUs) on May 23, 2024.
• The RSUs vest in three equal annual installments beginning on May 23, 2025.
• Each RSU represents the right to receive one share of Castle Biosciences' Common Stock.
• This Form 4/A is an amendment that restates the original Form 4 in its entirety.
• The reporting person directly owns the 6,777 derivative securities.

Sentiment

Score: 6

Explanation: The sentiment is neutral. It's a standard regulatory filing indicating insider activity, which can be interpreted as a positive sign of confidence, but doesn't provide enough information to strongly influence sentiment.

Positives

• The acquisition of RSUs by a director can be seen as a positive sign, indicating confidence in the company's future performance.

Future Outlook

The RSUs vest over three years, suggesting a long-term commitment by the director to the company's success.

Industry Context

Form 4 filings are standard practice for reporting changes in beneficial ownership by company insiders, providing transparency to investors.

Stakeholder Impact

• Shareholders may view the acquisition of RSUs by a director as a positive signal, aligning management's interests with theirs.

Key Dates